Annual Revenue
N/A
December 1, 2023
Summary
- CATX annual revenue is not available.
Performance
CATX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 1, 2024
Summary
- CATX quarterly revenue is not available.
Performance
CATX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 1, 2024
Summary
- CATX TTM revenue is not available.
Performance
CATX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
CATX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CATX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Perspective Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $3.55 M(-67.1%) | - | - |
| Sep 2022 | - | $1.72 M(-31.5%) | $9.95 M(-7.8%) |
| Jun 2022 | - | $2.50 M(-13.9%) | $10.79 M(-1.9%) |
| Jun 2022 | $10.79 M(+7.4%) | - | - |
| Mar 2022 | - | $2.91 M(+3.3%) | $11.00 M(+2.9%) |
| Dec 2021 | - | $2.82 M(+9.8%) | $10.69 M(+4.5%) |
| Sep 2021 | - | $2.56 M(-5.4%) | $10.23 M(+1.8%) |
| Jun 2021 | $10.05 M(+3.9%) | - | - |
| Jun 2021 | - | $2.71 M(+4.2%) | $10.05 M(+4.5%) |
| Mar 2021 | - | $2.60 M(+10.2%) | $9.62 M(-2.8%) |
| Dec 2020 | - | $2.36 M(-1.0%) | $9.90 M(+1.6%) |
| Sep 2020 | - | $2.38 M(+4.6%) | $9.75 M(+0.7%) |
| Jun 2020 | $9.68 M(+32.3%) | $2.28 M(-20.9%) | $9.68 M(+3.8%) |
| Mar 2020 | - | $2.88 M(+30.6%) | $9.32 M(+11.4%) |
| Dec 2019 | - | $2.21 M(-4.7%) | $8.37 M(+3.7%) |
| Sep 2019 | - | $2.31 M(+20.3%) | $8.07 M(+10.3%) |
| Jun 2019 | $7.31 M(+23.5%) | $1.92 M(0.0%) | $7.31 M(+4.6%) |
| Mar 2019 | - | $1.92 M(+1.1%) | $6.99 M(+5.3%) |
| Dec 2018 | - | $1.90 M(+21.9%) | $6.64 M(+5.9%) |
| Sep 2018 | - | $1.56 M(-2.6%) | $6.27 M(+5.9%) |
| Jun 2018 | $5.92 M(+24.4%) | $1.60 M(+1.9%) | $5.92 M(+4.1%) |
| Mar 2018 | - | $1.57 M(+2.4%) | $5.69 M(+5.4%) |
| Dec 2017 | - | $1.54 M(+26.8%) | $5.40 M(+10.4%) |
| Sep 2017 | - | $1.21 M(-11.6%) | $4.89 M(+2.7%) |
| Jun 2017 | $4.76 M(-0.2%) | $1.37 M(+6.9%) | $4.76 M(+5.5%) |
| Mar 2017 | - | $1.28 M(+24.7%) | $4.51 M(+1.9%) |
| Dec 2016 | - | $1.03 M(-4.9%) | $4.43 M(-3.5%) |
| Sep 2016 | - | $1.08 M(-3.5%) | $4.59 M(-3.8%) |
| Jun 2016 | $4.77 M(+3.5%) | $1.12 M(-6.6%) | $4.77 M(-4.4%) |
| Mar 2016 | - | $1.20 M(+0.8%) | $4.99 M(+0.8%) |
| Dec 2015 | - | $1.19 M(-5.7%) | $4.95 M(+2.6%) |
| Sep 2015 | - | $1.26 M(-5.9%) | $4.82 M(+4.8%) |
| Jun 2015 | $4.61 M(+9.2%) | $1.34 M(+15.7%) | $4.61 M(+9.3%) |
| Mar 2015 | - | $1.16 M(+8.7%) | $4.22 M(+0.6%) |
| Dec 2014 | - | $1.07 M(+2.3%) | $4.19 M(-0.5%) |
| Sep 2014 | - | $1.04 M(+9.8%) | $4.21 M(-0.2%) |
| Jun 2014 | $4.22 M | $949.50 K(-16.3%) | $4.22 M(-6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $1.13 M(+4.5%) | $4.51 M(-2.5%) |
| Dec 2013 | - | $1.09 M(+3.4%) | $4.63 M(+2.4%) |
| Sep 2013 | - | $1.05 M(-15.5%) | $4.52 M(-0.1%) |
| Jun 2013 | $4.53 M(-10.8%) | $1.24 M(-0.8%) | $4.53 M(-1.5%) |
| Mar 2013 | - | $1.25 M(+28.3%) | $4.59 M(-1.4%) |
| Dec 2012 | - | $975.50 K(-7.6%) | $4.66 M(-5.2%) |
| Sep 2012 | - | $1.06 M(-19.5%) | $4.91 M(-3.1%) |
| Jun 2012 | $5.07 M(-3.2%) | $1.31 M(-0.4%) | $5.07 M(+1.1%) |
| Mar 2012 | - | $1.32 M(+7.2%) | $5.02 M(-1.8%) |
| Dec 2011 | - | $1.23 M(+1.3%) | $5.11 M(-0.3%) |
| Sep 2011 | - | $1.21 M(-3.4%) | $5.13 M(-2.2%) |
| Jun 2011 | $5.24 M(-0.9%) | $1.26 M(-11.0%) | $5.24 M(-1.5%) |
| Mar 2011 | - | $1.41 M(+13.3%) | $5.32 M(+4.1%) |
| Dec 2010 | - | $1.24 M(-6.2%) | $5.11 M(-2.4%) |
| Sep 2010 | - | $1.33 M(-0.6%) | $5.23 M(-1.0%) |
| Jun 2010 | $5.29 M(-2.4%) | $1.34 M(+11.0%) | $5.29 M(+2.5%) |
| Mar 2010 | - | $1.20 M(-12.1%) | $5.16 M(-3.1%) |
| Dec 2009 | - | $1.37 M(-0.8%) | $5.32 M(+0.8%) |
| Sep 2009 | - | $1.38 M(+14.4%) | $5.28 M(-2.6%) |
| Jun 2009 | $5.42 M(-24.3%) | $1.21 M(-11.8%) | $5.42 M(-9.3%) |
| Mar 2009 | - | $1.37 M(+3.0%) | $5.97 M(-6.5%) |
| Dec 2008 | - | $1.33 M(-12.7%) | $6.39 M(-6.3%) |
| Sep 2008 | - | $1.52 M(-13.7%) | $6.82 M(-4.7%) |
| Jun 2008 | $7.16 M(+24.8%) | $1.76 M(-1.3%) | $7.16 M(+1.5%) |
| Mar 2008 | - | $1.78 M(+1.4%) | $7.05 M(+2.0%) |
| Dec 2007 | - | $1.76 M(-5.2%) | $6.91 M(+5.2%) |
| Sep 2007 | - | $1.86 M(+12.3%) | $6.57 M(+14.5%) |
| Jun 2007 | $5.74 M(+187.7%) | $1.65 M(+0.4%) | $5.74 M(+17.0%) |
| Mar 2007 | - | $1.65 M(+16.4%) | $4.90 M(+31.2%) |
| Dec 2006 | - | $1.41 M(+37.9%) | $3.74 M(+33.0%) |
| Sep 2006 | - | $1.03 M(+25.4%) | $2.81 M(+40.8%) |
| Jun 2006 | $1.99 M(-75.9%) | $817.90 K(+70.7%) | $1.99 M(+69.5%) |
| Mar 2006 | - | $479.20 K(-1.4%) | $1.18 M(+68.7%) |
| Dec 2005 | - | $486.20 K(+130.5%) | $697.10 K(+230.5%) |
| Sep 2005 | - | $210.90 K | $210.90 K |
| Sep 1996 | $8.26 M(+5.6%) | - | - |
| Sep 1995 | $7.82 M(+15.2%) | - | - |
| Sep 1994 | $6.79 M | - | - |
FAQ
- What is the all time high annual revenue for Perspective Therapeutics?
- What is the all time high quarterly revenue for Perspective Therapeutics?
- What is the all time high TTM revenue for Perspective Therapeutics?
What is the all time high annual revenue for Perspective Therapeutics?
Perspective Therapeutics all-time high annual revenue is $10.79 M
What is the all time high quarterly revenue for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly revenue is $2.91 M
What is the all time high TTM revenue for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM revenue is $11.00 M